Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001066372 | SCV001231379 | uncertain significance | Imerslund-Grasbeck syndrome | 2020-02-24 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine with alanine at codon 1034 of the CUBN protein (p.Gly1034Ala). The glycine residue is highly conserved and there is a small physicochemical difference between glycine and alanine. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals with CUBN-related conditions. This variant is present in population databases (rs778092585, ExAC 0.006%). |
Fulgent Genetics, |
RCV002489698 | SCV002789791 | uncertain significance | Imerslund-Grasbeck syndrome type 1; Proteinuria, chronic benign | 2022-04-18 | criteria provided, single submitter | clinical testing |